Page 11 - Health

Artificial intelligence can be helpful in diabetes monitoring, prevention

Artificial intelligence can be used to turn a continuous glucose monitor (CGM) into a potent tool for diabetes monitoring and prevention, suggests researchers at Klick Applied Sciences

India lacks adequate community level data for hypertension control: Lancet

More than 50 per cent of patients in India are unaware of their high blood pressure, finds a study published in Lancet Regional Health Journal

Research shows migraines caused by alterations in metabolite levels

Migraines are a pain in the head and in the hip pocket, but newly discovered genetic causes by QUT researchers could lead the way to new preventative drugs and therapies

Akums chalks out expansion plan as it eyes Rs 10,000 cr turnover by 2028

Leading contract manufacturing drug firm Akums Drugs & Pharmaceuticals plans to expand its presence globally and enhance product range as it looks to more than double its turnover to Rs 10,000 crore by 2028, as per the company's Joint Managing Director Sandeep Jain. The company, which produces around 12 per cent of all the medicines consumed in the country from its 15 manufacturing facilities, has a topline of about Rs 4,000 crore currently. In an interaction with PTI, Jain said the company would be able to achieve its stated financial targets even if it continues to grow at the same pace it has been doing over the last few years. He noted that the demand for pharmaceutical products is going to stay robust in the domestic market, with some estimates pointing towards the market doubling by 2030. "We expect to touch a turnover of Rs 10,000 crore in the next five years (2028)from the current level of Rs 4,000 crore. Our plan is to keep growing by at least 12-15 (CAGR)," Jain ...

Korea thought it was ready for Covid, now it's eyeing the next threat

South Korea had one of the world's lowest Covid fatality rates, with the third-fewest deaths per 100,000 people out of the 38 members of the Organisation for Economic Co-operation and Development

'He is still critical, not passed yet,' says Vikram Gokhale's daughter

There are no details concerning his illness, and neither the family nor the hospital has released any official statement of his health condition yet

Dettol enters a new category with Dettol multi-use antiseptic cream

With the launch of this antiseptic cream, the company aims to create a niche for itself in the cuts and wounds segment, as it looks to on building on its existing antiseptic liquid

Adult cancer survivors at higher risk of bone fractures, say researchers

Among cancer survivors 5 or more years after diagnosis, physical exercise may be related to a lower risk of fracture and that continued smoking was associated with a greater risk

Donating blood? Eligibility to advantages, here're things to keep in mind

Every person can donate on a regular basis. Men can donate every three months and women can donate every four months

FM asks AIIB to scale up investments in clean energy, infrastructure

India on Wednesday asked Beijing-based multilateral lending agency AIIB to scale up investments in priority areas like clean energy and infrastructure sector with a special focus on education and health. Addressing the annual meeting of the Board of Governors of the Asian Infrastructure Investment Bank (AIIB), Finance Minister Nirmala Sitharaman said India has embarked on the path of a self-reliant economy and therefore has been successful in mitigating the negative effects of the pandemic. As regards AIIB, she said, it needs to scale-up investments in key priority areas, including clean energy and energy efficiency, disaster resilient infrastructure, social infrastructure with a special focus on education and health, and digital infrastructure in order to ensure a meaningful impact is achieved and resources are not scattered in multiple areas. As public resources alone are insufficient to meet the vast infrastructure needs of the members, she advised that the bank should not only .

WHO epidemiologist issues new advisory amid rise in Omicron variants

While the new Covid variants are causing fear worldwide, in India, they do not lead to more hospital admissions and deaths. Though it is considered mild, the new variants are still fast-spreading ones

New Covid variants spreading across the globe: what are the risk?

Amid the surge in the new and recombinant variants, scientists across the world are now watching out for variants which could turn into variants of concern soon

Physical inactivity may cost the world $300 bn between 2020 and 2030: WHO

Around 500 mn people will develop heart disease, obesity, diabetes or other non-communicable diseases (NCDs) due to physical inactivity, WHO's 'Global Status Report on Physical Activity 2022' says

Temporary Covid-19 centres getting dismantled amid signs pandemic is ending

About 92% of cases in India are said to be having mild disease. In only 5.8% of cases oxygen therapy is required, intensive care in only 1.7% cases

Glenmark launches drug to treat patients with insulin-resistant diabetes

Glenmark Pharmaceuticals on Thursday said it has launched Thiazolidinedione Lobeglitazone in the country for the treatment of type 2 diabetes in adults. The Mumbai-based drug firm has launched the medication under the brand name LOBG and is priced at around Rs 10 per tablet. Indians have a high prevalence of insulin resistance and that makes LOBG an appealing treatment option in managing uncontrolled Type 2 diabetes among insulin-resistant diabetic patients, Glenmark Pharmaceuticals said in a statement. The company had received approval from the Indian drug regulator, Drug Controller General of India, for manufacturing and marketing Lobeglitazone, based on a randomised, double-blind Phase 3 clinical trial conducted on adult Type 2 diabetic patients, aged 18 years and older. "As per the International Diabetes Federation, diabetes affects 74 million adults in India, of which, around 40 per cent of them seem to be insulin-resistant... "We are proud to introduce LOBG; an innovative an

Alzheimer's-related deaths in India increased 5 times in 30 years

Lancet study: Alzheimer's and other dementias claimed 129,000 lives in 2019

India reports 3,805 fresh Covid-19 cases, 26 deaths: Health Ministry

In the last 24 hours, India reported 3,805 fresh Covid-19 cases ad 26 deaths, the Union Health Ministry said on Saturday.

Diabetes burden: India lost 45 years of healthy life per person in 2021

By 2040, Type 1 diabetes cases to increase by 116% in India, says Lancet study

Low testing, climate change hamper India's fight against Dengue and Malaria

Experts say India needs more decentralised planning, and access to testing and treatment for malaria and dengue

Repeated infections increase risk of neurodegenerative diseases: Study

Infections treated with speciality hospital care in early and mid-life are associated with an increased subsequent risk of Alzheimer's (AD) and Parkinson's diseases (PD), according to a new study.